Literature DB >> 12603311

Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation.

David Lando1, Jeffrey J Gorman, Murray L Whitelaw, Daniel J Peet.   

Abstract

To sustain life mammals have an absolute and continual requirement for oxygen, which is necessary to produce energy for normal cell survival and growth. Hence, maintaining oxygen homeostasis is a critical requirement and mammals have evolved a wide range of cellular and physiological responses to adapt to changes in oxygen availability. In the past few years it has become evident that the transcriptional protein complex hypoxia-inducible factor (HIF) is a key regulator of these processes. In this review we will focus on the way oxygen availability regulates HIF proteins and in particular we will discuss the way oxygen-dependent hydroxylation of specific amino acid residues has been demonstrated to regulate HIF function at the level of both protein stability and transcriptional potency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603311     DOI: 10.1046/j.1432-1033.2003.03445.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  30 in total

1.  Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.

Authors:  Akulapalli Sudhakar; Pia Nyberg; Venkateshwar G Keshamouni; Arjuna P Mannam; Jian Li; Hikaru Sugimoto; Dominic Cosgrove; Raghu Kalluri
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

Review 2.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

3.  The GCN4 bZIP targets noncognate gene regulatory sequences: quantitative investigation of binding at full and half sites.

Authors:  I-San Chan; Anna V Fedorova; Jumi A Shin
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

4.  HIF-1alpha: a valid therapeutic target for tumor therapy.

Authors:  Soon-Sun Hong; Hyunseung Lee; Kyu-Won Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

5.  High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.

Authors:  Johannes Schödel; Spyros Oikonomopoulos; Jiannis Ragoussis; Christopher W Pugh; Peter J Ratcliffe; David R Mole
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

6.  Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing.

Authors:  C Hernández; E Santamatilde; K J McCreath; A M Cervera; I Díez; D Ortiz-Masiá; N Martínez; S Calatayud; J V Esplugues; M D Barrachina
Journal:  Br J Pharmacol       Date:  2008-12-09       Impact factor: 8.739

Review 7.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

Review 8.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

9.  Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts.

Authors:  David R Mole; Christine Blancher; Richard R Copley; Patrick J Pollard; Jonathan M Gleadle; Jiannis Ragoussis; Peter J Ratcliffe
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

Review 10.  Tracheal remodelling in response to hypoxia.

Authors:  Lazaro Centanin; Thomas A Gorr; Pablo Wappner
Journal:  J Insect Physiol       Date:  2009-06-10       Impact factor: 2.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.